We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Pfizer Inc. (NYSE:PFE) is one of the ...

We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Merck & Co., Inc. (NYSE:MRK) is one of ...

In this piece, we will look at the stocks Jim Cramer recently discussed.

Famed short-seller Andrew Left's Citron Research publicly challenged CNBC's Jim Cramer over his bullish stance on Palantir ...

Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks ...

Pfizer (NYSE:PFE) develops and sells biopharmaceutical products, including vaccines, treatments for infectious diseases, ...

U.S. equities declined in Tuesday’s midday trade after surging during the morning session, after President Donald Trump ...

Over 100 major companies — including MicroStrategy, Coinbase, AMD, Pfizer, and Boeing — are set to report earnings today, ...

CNBC’s Jim Cramer unpacked the Federal Reserve’s decision to hold interest rates steady.

CNBC's Jim Cramer on Wednesday explained why he's positive on Starbucks for the long term, even as the coffee chain reported a same-store sales decline that led to a choppy day of trading. "If ...

CNBC’s Jim Cramer warned that Trump tariffs are starting to hurt consumers after UPS, Whirlpool, and Stanley Black & Decker reported “jarring quarters.” ...

CNBC's Jim Cramer on Tuesday reviewed Figma, a design software company set to go public this week. Although he said he likes Figma's underlying business, he's hesitant to recommend the stock right ...